Biocept Financials
BIOCDelisted Stock | USD 1.45 0.17 13.28% |
Biocept |
Understanding current and past Biocept Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biocept's financial statements are interrelated, with each one affecting the others. For example, an increase in Biocept's assets may result in an increase in income on the income statement.
Please note, the presentation of Biocept's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biocept's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biocept's management manipulating its earnings.
Biocept Stock Summary
Biocept competes with Ibio, Aytu BioScience, and Actinium Pharmaceuticals. Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Biocept operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 177 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US09072V5012 |
Business Address | 9955 Mesa Rim |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | biocept.com |
Phone | 858 320 8200 |
Currency | USD - US Dollar |
Biocept Key Financial Ratios
Biocept Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biocept's current stock value. Our valuation model uses many indicators to compare Biocept value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biocept competition to find correlations between indicators driving Biocept's intrinsic value. More Info.Biocept is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biocept's earnings, one of the primary drivers of an investment's value.Biocept Market Pulse
Quote | 1.45 |
Change(%) | 13.28 |
Change | 0.17 |
Open | 1.28 |
Low | 1.28 |
High | 1.55 |
Volume | 0 |
Exchange | NASDAQ |
About Biocept Financials
What exactly are Biocept Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Biocept's income statement, its balance sheet, and the statement of cash flows. Potential Biocept investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biocept investors may use each financial statement separately, they are all related. The changes in Biocept's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biocept's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Biocept December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biocept help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biocept. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biocept based on widely used predictive technical indicators. In general, we focus on analyzing Biocept Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biocept's daily price indicators and compare them against related drivers.
Information Ratio | (0.29) | |||
Maximum Drawdown | 66.54 | |||
Value At Risk | (15.27) | |||
Potential Upside | 9.24 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Biocept Stock
If you are still planning to invest in Biocept check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biocept's history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |